Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Using a paravertebral block during thoracic (VATS/RATS) surgery to reduce postoperative complications

Official title: Perioperative Paravertebral Block Reduces Postoperative Complications in Thoracic Surgery: An Observational Study

Run by Tongji Hospital · NCT07211529 · Data updated 2026-11-12

This study will try an intraoperative paravertebral block to see if it lowers postoperative complications in adults having VATS or RATS for lung or mediastinal procedures.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment500 (estimated)
SponsorTongji Hospital
Academic / other
Locations1 site (Wuhan, Hubei)
StatusRecruiting
StartedMarch 25, 2025
Main results expectedMay 31, 2028
Study endsDecember 31, 2028
Registry record updatedOctober 8, 2025
Trial IDNCT07211529 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older scheduled for VATS or RATS (wedge resection, segmentectomy, lobectomy, or mediastinal surgery) who can give informed consent and are treated by anesthesiologists trained in ultrasound-guided PVB.

Probably not a fit

Patients converted to open thoracotomy, with prior ipsilateral thoracic surgery, who do not complete the planned surgery, or who are lost to follow-up are unlikely to receive benefit from participation or from study findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study with retrospective and prospective components conducted at Tongji Hospital campuses, focusing on patients undergoing thoracic operations such as wedge resection, segmentectomy, lobectomy, or mediastinal surgery. Retrospectively, prior cases in which an intraoperative paravertebral block (PVB) was used will be analyzed for associations with postoperative complications. Prospectively, perioperative biomarkers (including MMP3, neutrophils, leukocytes, PCT, CRP) and clinical measures (pain and cough scores, time to first flatus and defecation) will be collected, with 30-day follow-up for postoperative complications. The study will correlate biochemical markers with clinical outcomes to explore potential prognostic relationships.

Why it matters

Potential benefit: If successful, using intraoperative paravertebral block could reduce postoperative complications and speed recovery after thoracic minimally invasive surgery.

How similar studies have gone: Prior randomized and observational studies have shown PVB reduces postoperative pain and opioid use and some suggest fewer pulmonary complications, but results vary and definitive evidence on complication reduction is still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male or female participants aged 18 years or older.
2. Scheduled to undergo thoracic surgery via Video-Assisted Thoracoscopic Surgery (VATS) or Robotic-Assisted Thoracoscopic Surgery (RATS), including wedge resection, segmentectomy, lobectomy, or mediastinal surgery.
3. Signed informed consent obtained prior to study participation. -

Exclusion Criteria:

1. Patients who refuse to provide informed consent.
2. Anesthesiologists who have not received training in ultrasound-guided paravertebral block (PVB-US).
3. History of ipsilateral thoracic surgery.
4. Conversion to open thoracotomy during the procedure.
5. Patients who did not complete the scheduled surgery due to disease progression or medical reasons.
6. Patients who are lost to follow-up or refuse postoperative follow-up. -

Where it's running

  • Tongji Medical College of HUST: Huazhong University of Science and Technology Tongji Medical College Tongji Hospital
    Wuhan, Hubei, China
    Recruiting

Study contacts

  • Principal investigator: Zhang qin Zhang — Huazhong keji daxue tongji yixue yuan fushu tongji yiyuan
  • Study coordinator: Guo jiateng Guo
  • Email: 18737552580@163.com
  • Phone: 18737552580

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.